This article is intended for primary care clinicians, dermatologists, and other specialists who care for newborn infants.
The goal of this activity is to provide medical news to primary care clinicians and other healthcare professionals in order to enhance patient care.
Upon completion of this activity, participants will be able to:
As an organization accredited by the ACCME, Medscape, LLC requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.
Medscape, LLC encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Medscape, LLC designates this educational activity for a maximum of 0.25
AMA PRA Category 1 Credit(s)™
. Physicians should only claim credit commensurate with the extent of their participation in the activity. Medscape Medical News has been reviewed and is acceptable for up to 350 Prescribed credits by the American Academy of Family Physicians. AAFP accreditation begins 09/01/08. Term of approval is for 1 year from this date. This activity is approved for 0.25 Prescribed credits. Credit may be claimed for 1 year from the date of this activity.
Note: Total credit is subject to change based on topic selection and article length.
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability
and acceptance of continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the
activity online during the valid credit period that is noted on the title page.
Follow these steps to earn CME/CE credit*:
CME Released: 1/11/2008; Reviewed and Renewed: 2/11/2009
Valid for credit through: 2/11/2010, 11:59 PM EST
processing....
January 11, 2008 — Clinicians who care for infants must be able to identify common skin lesions and counsel parents appropriately, according to a review article published in the January 1 issue of the American Family Physician. The study authors summarize the presentation, prognosis, and treatment of the rashes most often presenting during the first 4 weeks of life.
"A newborn's skin may exhibit a variety of changes during the first four weeks of life, write Nina R. O'Connor, MD, from the Chestnut Hill Hospital Family Practice Residency Program in Philadelphia, Pennsylvania, and colleagues. "Most of these changes are benign and self-limited, but others require further work-up for infectious etiologies or underlying systemic disorders. Nearly all of these skin changes are concerning to parents and may result in visits to the physician or questions during routine newborn examinations."
Transient vesiculopustular rashes that can be diagnosed clinically, based on their distinctive appearances, are erythema toxicum neonatorum, acne neonatorum, and transient neonatal pustular melanosis.
The most common pustular eruption during the first month of life is erythema toxicum neonatorum, affecting 40% to 70% of newborns. Typical lesions are erythematous, 2- to 3-mm macules and papules that evolve into pustules on the face, trunk, and proximal part of the limbs, each surrounded by a blotchy area of erythema.
Acne neonatorum, which is present in nearly one fifth of newborns, is characterized by closed comedones on the forehead, nose, and cheeks. Other locations, as well as development of open comedones, inflammatory papules, and pustules, are less common.
Transient neonatal pustular melanosis is a vesiculopustular rash affecting 5% of black newborns and less than 1% of white newborns. Unlike erythema toxicum neonatorum, transient neonatal pustular melanosis lesions have no surrounding erythema; rupture easily; and affect all areas of the body, including the palms and soles.
When rashes are accompanied by signs of systemic illness or unusual presentations, infants should be evaluated for Candida, viral, and bacterial infections.
In the newborn, immaturity of skin structures may give rise to milia and miliaria. Heat rash, or miliaria rubra, usually improves with cooling measures. Milia, present in nearly half of newborns, are 1- to 2-mm pearly white or yellow papules caused by keratin retention within the dermis. They usually disappear spontaneously within the first month of life but may persist into the second or third month, so parents should be reassured about their benign, self-limited course.
Miliaria results from sweat retention caused by partial closure of eccrine structures, occurs in up to 40% of infants, and usually appears during the first month of life.
Seborrheic dermatitis, characterized by erythema and greasy scales, is highly prevalent during the first 4 weeks of life, and it needs to be differentiated from atopic dermatitis. Seborrheic dermatitis, or "cradle cap," occurs most commonly on the scalp, but it may also affect the face, ears, and neck. Management of seborrheic dermatitis usually consists of parental reassurance and observation, but tar-based shampoo, topical ketoconazole, or mild topical steroids may be required for treatment of severe or persistent cases.
Features that help to differentiate seborrheic and atopic dermatitis in infancy include age at onset, which is usually within the first month, vs after 3 months of age, respectively. The course of seborrheic dermatitis is self-limited and responds to treatment, whereas atopic dermatitis responds to treatment but often relapses. Seborrheic dermatitis affects the scalp, face, ears, neck, and diaper area, and atopic dermatitis affects the scalp, face, trunk, extremities, and diaper area. Pruritus is infrequent with seborrheic dermatitis but is highly prevalent with atopic dermatitis.
Specific clinical recommendations and their corresponding level of evidence rating are as follows:
"If seborrheic dermatitis persists despite a period of watchful waiting, several treatment options exist," the review authors write. "Tar-containing shampoos can be recommended as first-line treatment. Selenium sulfide shampoos are probably safe, but rigorous safety data in infants is lacking. The use of salicylic acid is not recommended because of concerns about systemic absorption."
The review authors have disclosed no relevant financial relationships.
Am Fam Physician. 2008;77:47-52.
Rashes are very common in newborns and can be a source of concern for parents, but most are transient and benign. Only unusual or atypical presentations usually require a workup for infection, with the majority of rashes resolving with time. This is a review of common rashes in newborns and the recommended strategies for management.